Immunological Mechanisms of Low and Ultra-Low Dose Cancer Chemotherapy


Traditionally, anticancer chemotherapy has been generally considered to be strongly immunosuppressive. However, increasing evidence suggests that certain chemotherapeutic agents rely on the induction of antitumor immune responses, in both experimental animal models and patients with cancer. Many of these chemotherapeutic agents exert immunogenic effects via… (More)
DOI: 10.1007/s12307-013-0141-3


1 Figure or Table

Slides referencing similar topics